CLINICAL_TRIALS
trial_result
· 2018-04-24
Clinical Trial Update: A Study of LY2409021 in Patients With Type 2 Diabetes [Phase 2]
Summary
A Phase 2 trial of LY2409021 in patients with Type 2 diabetes has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2018-04-24